Nu-Med Plus (NUMD) Assets Growth (5y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Nu-Med Plus | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -57.30% |
| Sep 30, 2025 | -62.15% |
| Jun 30, 2025 | -60.53% |
| Mar 31, 2025 | -35.74% |
| Dec 31, 2024 | -27.18% |
| Sep 30, 2024 | -39.39% |
| Jun 30, 2024 | -26.87% |
| Mar 31, 2024 | -43.35% |
| Dec 31, 2023 | -49.82% |
| Sep 30, 2023 | -52.23% |
| Jun 30, 2023 | -35.86% |
| Mar 31, 2023 | -28.90% |
| Dec 31, 2022 | -27.85% |
| Sep 30, 2022 | -63.04% |
| Jun 30, 2022 | -51.58% |
| Mar 31, 2022 | -53.11% |
| Dec 31, 2021 | -9.01% |
| Sep 30, 2021 | -27.33% |
| Jun 30, 2021 | -37.64% |
| Mar 31, 2021 | 17.51% |
| Dec 31, 2020 | 48.97% |
| Sep 30, 2020 | 59.60% |
| Jun 30, 2020 | 56.49% |
| Mar 31, 2020 | -14.04% |
| Dec 31, 2019 | -26.48% |
| Sep 30, 2019 | -17.05% |
| Jun 30, 2019 | -37.27% |
| Mar 31, 2019 | -20.98% |
| Dec 31, 2018 | 34.52% |
| Sep 30, 2018 | 52.66% |
| Jun 30, 2018 | 36.99% |
| Mar 31, 2018 | 35.89% |
| Dec 31, 2017 | 29.80% |
| Dec 31, 2016 | 90.78% |